C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) C12Q 1/42 (2006.01) C12N 9/16 (2006.01) C12N 15/55 (2006.01)
Patent
CA 2495529
Diagnostic and therapeutic applications for Noonan Syndrome are described. The diagnostic and therapeutic applications are based on certain mutations in the protein tyrosine phosphatase gene PTPN11 and its expression product, PTPN11. Also described are nucleotide sequences, amino acid sequences, probes, and primers related to PTPN11 and PTP11 variants, and cells expressing such variants.
L'invention concerne des applications diagnostiques et thérapeutiques visant le syndrome de Noonan. Les applications diagnostiques et thérapeutiques sont basées sur certaines mutations dans le gène des protéines tyrosine phosphatase <i>PTPN11</i> et sur son produit d'expression <i>PTPN11</i>. L'invention décrit aussi des séquences nucléotidiques, des séquences d'acides amines, des sondes et des amorces liées à <i>PTPN11</i> et aux variants de <i>PTP11</i> ainsi que des cellules exprimant ces variants.
Gelb Bruce D.
Tartaglia Marco
Mount Sinai School Of Medicine Of New York University
Robic
LandOfFree
Noonan syndrome gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Noonan syndrome gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Noonan syndrome gene will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1723042